| Bioactivity | SARS-CoV-2-IN-97 (Compound CO-01) is an inhibitor for SARS-CoV-2 Nsp15 endoribonuclease with an IC50 of 53.5 μM. SARS-CoV-2-IN-97 exhibits low cytotoxicity in A549-AT cell with IC50 of 134 μM[1]. |
| CAS | 364338-71-6 |
| Formula | C11H3Br2N3O |
| Molar Mass | 352.97 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Rampias T, et al. Exploration of isatin-based inhibitors of SARS-CoV-2 Nsp15 endoribonuclease[J]. European Journal of Medicinal Chemistry, 2024: 116886. |
SARS-CoV-2-IN-97
CAS: 364338-71-6 F: C11H3Br2N3O W: 352.97
SARS-CoV-2-IN-97 (Compound CO-01) is an inhibitor for SARS-CoV-2 Nsp15 endoribonuclease with an IC50 of 53.5 μM. SARS-C
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.